Showing results (741-750 of 1,615) with videos related to
Sort By:
Pageof 162
Cancer Journal (Sudbury, Mass.)|October 15, 2009
Tumor shrinkage and objective response rates: gold standard for oncology efficacy screening trials, or an outdated end point?Penelope Bradbury, Lesley SeymourCancer Journal (Sudbury, Mass.)|October 15, 2009
Overall survival: a gold standard in search of a surrogate: the value of progression-free survival and time to progression as end points of drug efficacySen H Zhuang, Liang Xiu, Yusri A ElsayedCancer Journal (Sudbury, Mass.)|October 15, 2009
Other paradigms: better treatments are identified by better trials: the value of randomized phase II studiesManish R Sharma, Michael L Maitland, Mark J RatainCancer Journal (Sudbury, Mass.)|April 15, 2017
Applied Cancer Immunogenomics: Leveraging Neoantigen Discovery in GlioblastomaTanner M Johanns, Gavin P DunnCancer Journal (Sudbury, Mass.)|March 23, 2023
The Microbiome and Its Impact on Allogeneic Hematopoietic Cell TransplantationFlorent Malard, Robert R JenqCancer Journal (Sudbury, Mass.)|March 23, 2023
Radiation Therapy and the Microbiome; More Than a Gut FeelingUri Amit, Andrea Facciabene, Edgar Ben-JosefCancer Journal (Sudbury, Mass.)|March 23, 2023
Microbiome and Diet in Colon Cancer Development and TreatmentIkuko Kato, Jun SunCancer Journal (Sudbury, Mass.)|January 23, 2026
Modern Surgical Approaches for Brain MetastasesAlexander Becker, Alejandro Carrasquilla, Michael A VogelbaumCancer Journal (Sudbury, Mass.)|January 23, 2026
Biology of Brain MetastasesOzum Atasoy, Eyub Y Akdemir, Rupesh KotechaPageof 162